BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu J, Guo J, Wang D, Yu J, Gu T, Jiang C, Kong W, Wu Y. Broad protective immune responses elicited by bacterium-like particle-based intranasal pneumococcal particle vaccine displaying PspA2 and PspA4 fragments. Hum Vaccin Immunother 2019;15:371-80. [PMID: 30235046 DOI: 10.1080/21645515.2018.1526556] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Figueiredo DB, Kaneko K, Rodrigues TDC, MacLoughlin R, Miyaji EN, Saleem I, Gonçalves VM. Pneumococcal Surface Protein A-Hybrid Nanoparticles Protect Mice from Lethal Challenge after Mucosal Immunization Targeting the Lungs. Pharmaceutics 2022;14:1238. [PMID: 35745810 DOI: 10.3390/pharmaceutics14061238] [Reference Citation Analysis]
2 Gonçalves VM, Kaneko K, Solórzano C, MacLoughlin R, Saleem I, Miyaji EN. Progress in mucosal immunization for protection against pneumococcal pneumonia. Expert Rev Vaccines 2019;18:781-92. [PMID: 31305196 DOI: 10.1080/14760584.2019.1643719] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhang Y, Guo X, Guo M, Chen X, Li B, Yu J, Gu T, Kong W, Wu Y. Combined prime-boost immunization with systemic and mucosal pneumococcal vaccines based on Pneumococcal surface protein A to enhance protection against lethal pneumococcal infections. Immunol Res 2019;67:398-407. [PMID: 31773490 DOI: 10.1007/s12026-019-09107-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Masomian M, Ahmad Z, Gew LT, Poh CL. Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection. Vaccines (Basel) 2020;8:E132. [PMID: 32192117 DOI: 10.3390/vaccines8010132] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]